胸腺瘤伴重症肌无力患者胸腺切除术后肌无力危象的危险因素
该回顾性研究纳入127例胸腺瘤伴重症肌无力行全胸腺切除术的患者,10%发生术后肌无力危象需插管。多因素分析显示WHO B2-B3型和Osserman IIA-IV期是独立预测因素。
要点
- Osserman IIA-IV期和WHO B2-B3型是术后肌无力危象独立预测因素。
- 术后肌无力危象发生率10%,均经插管通气后脱机出院。
- 对高危患者应加强围手术期管理。
核心结论
- Osserman IIA-IV期和WHO B2-B3型胸腺瘤是胸腺瘤伴重症肌无力患者全胸腺切除术后肌无力危象的独立预测因素。
研究设计与样本
- 回顾性分析2005至2014年单中心127例胸腺瘤伴重症肌无力行全胸腺切除术患者的临床记录,男68例女59例,中位年龄50岁。
主要发现
- 13例(10%)发生术后肌无力危象需插管,插管时间2-28天(中位9天),均脱机出院。
- 单因素分析显示Osserman IIA-IV期OR=4.928(95%CI 1.286-18.882,P=0.01)、球部症状OR=3.828(95%CI 1.112-13.176,P=0.04)、FEV1<70%预计值OR=4.856(95%CI 1.380-17.081,P=0.02)与术后肌无力危象相关。
- WHO B2-B3型较A-B1型术后肌无力危象更常见(OR=8.118,95%CI 1.020-64.590,P=0.03)。
- 多因素logistic回归显示WHO B2-B3型(OR=10.041,95%CI 1.228-82.090,P=0.03)和Osserman IIA-IV期(OR=5.953,95%CI 1.506-23.538,P=0.01)独立预测术后肌无力危象。
临床怎么用
- 对Osserman IIA-IV期或WHO B2-B3型胸腺瘤伴重症肌无力患者,应加强围手术期监护和呼吸支持准备。
局限性
- 回顾性单中心研究,样本量有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Total thymectomy should be performed on thymoma patients with myasthenia gravis. The aim of the present study was to investigate the risk factors of postoperative myasthenic crisis (POMC) occurrence in these patients. METHODS: The clinical records of 127 thymoma patients with myasthenia gravis (68 men, 59 women; median age, 50 years) who underwent total thymectomy at our institution from 2005 to 2014 were retrospectively reviewed. The following factors were analysed in relation to POMC: gender, age, duration of symptoms, bulbar symptoms, smoking history, history of myasthenic crisis, comorbidities, perioperative pyridostigmine and prednisolone therapy, spirometric and blood gas parameters, Osserman stage, operation approach, major complications, World Health Organization (WHO) histologic classification, Masaoka stage and use of immunoglobulins or plasmapheresis. RESULTS: Thirteen patients (10%) experienced POMC and required intubation. All patients were weaned after 2-28 days (median 9 days) and were discharged. Univariate analysis revealed a correlation between POMC and Osserman-stage IIA-IV [odds ratio (OR) = 4.928, 95% confidence interval (CI) = 1.286-18.882, P = 0.01], bulbar symptoms (OR = 3.828, 95% CI = 1.112-13.176, P = 0.04), and forced expiratory volume in one second <70% pred forced expiratory volume in one second (OR = 4.856, 95% CI = 1.380-17.081, P = 0.02). In addition, more frequent POMC occurred in WHO type B2-B3 than in type A-B1 thymomas (OR = 8.118, 95% CI = 1.020-64.590, P = 0.03). Multivariate logistic regression analysis showed that WHO histologic classification B2-B3 (OR = 10.041, 95% CI = 1.228-82.090, P = 0.03) and Osserman-stage IIA-IV (OR = 5.953, 95% CI = 1.506-23.538, P = 0.01) independently predicted POMC. CONCLUSIONS: Osserman stage (IIA-IV) and WHO type B2-B3 thymomas are independent predictors of POMC in thymoma patients with myasthenia gravis who have undergone total thymectomy. Thus, adequate perioperative care should be provided to these patients.
引用
- Xue L, Wang L, Dong J, et al. Risk factors of myasthenic crisis after thymectomy for thymoma patients with myasthenia gravis. Eur J Cardiothorac Surg. 2017. PMID: 29156018. doi:10.1093/ejcts/ezx163
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。